1. RESULTS OF PHASE II STUDY OF COMBINED IMMUNOTHERAPY WITH RITUXIMAB PLUS LYMPHOKINE‐ACTIVATED KILLER CELLS AS MAINTENANCE IN FOLLICULAR LYMPHOMA PATIENTS. (12th June 2019) Authors: Martinez Calle, N.; Diaz De Cerio, A.; Pena, E.; Garcia Muñoz, R.; Panizo, A.; Feliu, J.; Giraldo, P.; Rodriguez, M.; Grande, C.; Olave, T.; Andrade‐Campos, M.; Bandres, E.; Nuñez, J.; Inoges, S.; Panizo, C. Journal: Hematological oncology Issue: Volume 37(2019)Supplement 2 Page Start: 509 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗